CStone Pharmaceuticals - 2616.HK

2616.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
2616.HK	6.5	12.2	0	30.7	88.5	29.2	-70.0	-78.7	-82.1	-82.1
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare 2616.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	2616.HK
name	CStone Pharmaceuticals
price	2.3
changes percentage	6.4815
change	0.14
day low	2.19
day high	2.31
year high	2.78
year low	0.8
market cap	2935962818
price avg 50	2.2072
price avg 200	1.5515
exchange	HKSE
volume	823500
avg volume	2518815
open	2.2
previous close	2.16
eps	-0.12
pe	-19.17
earnings announcement	2025-03-25T10:59:00.000+0000
shares outstanding	1276505573
timestamp	2025-01-20 08:08:32

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 57.0%

Overall Quarterly Financial Health: 33.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	463842000	481363000	-3.64
gross profit	304295000	278378000	9.31
gross profit ratio	0.66	0.58	13.44
research and development expenses	527799000	614162000	-14.06
operating expenses	304295000	1181886000	-74.25
interest income	24886000	9672000	157.30
interest expense	11819000	8477000	39.42
ebitda	-297225000	-849661000	65.02
ebitdaratio	-0.64	-1.64	60.84
operating income	-534607000	-832272000	35.77
operating income ratio	-1.15	-1.73	33.34
net income	-367234000	-964607000	61.93
net income ratio	-0.79	-2.0	60.49
eps	-0.29	-0.82	64.63

Overall Score of Annual Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 464 million in 2023 from 481 million in 2022 representing a change of -3.64%. This indicates a sales shrinking, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 528 million in 2023 from 614 million in 2022 representing a change of -14.06%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 304 million in 2023 from 1,182 million in 2022 representing a change of -74.25%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -297 million in 2023 from -850 million in 2022 representing a change of 65.02%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -535 million in 2023 from -832 million in 2022 representing a change of 35.77%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -367 million in 2023 from -965 million in 2022 representing a change of 61.93%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 304 million in 2023 from 278 million in 2022 representing a change of 9.31%. This indicates a sales profitability growth, which is a positive sign for the company.

  Earnings per Share (EPS): EPS increased to -0.29 in 2023 from -0.29 in 2022 representing a change of 64.63%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	127082500	127082500	0.0
gross profit	86014500	86014500	0.0
gross profit ratio	0.68	0.68	0.0
research and development expenses	33124000	33124000	0.0
operating expenses	87844500	87844500	0.0
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	1611000	1611000	0.0
ebitdaratio	0.01	0.01	0.0
operating income	-1830000	-1830000	0.0
operating income ratio	-0.01	-0.01	0.0
net income	7849500	7849500	0.0
net income ratio	0.06	0.06	0.0
eps	0.01	0.01	0.0

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1661999000	1638427000	1.44
total liabilities	1205169000	1189101000	1.35
total equity	456830000	449326000	1.67
cash and cash equivalents	996671000	558684000	78.40
short term investments	30000000	483407000	-93.79
long term investments	-26459000	-479925000	94.49
total current assets	1329787000	1246917000	6.65
total non current assets	332212000	391510000	-15.15
total current liabilities	850338000	946482000	-10.16
total non current liabilities	354831000	242619000	46.25
common stock	860000	802000	7.23
retained earnings	-9019727000	-8652493000	-4.24
total debt	363448000	286290000	26.95

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,662 million in 2023 from 1,638 million in 2022 representing a change of 1.44%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 457 million in 2023 from 449 million in 2022 representing a change of 1.67%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 997 million in 2023 from 559 million in 2022 representing a change of 78.4%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,330 million in 2023 from 1,247 million in 2022 representing a change of 6.65%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 850 million in 2023 from 946 million in 2022 representing a change of -10.16%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 1 in 2023 from 1 in 2022 representing a change of 7.23%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,205 million in 2023 from 1,189 million in 2022 representing a change of 1.35%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 30 million in 2023 from 483 million in 2022 representing a change of -93.79%. This indicates a decrease in short-term investment holdings.

  Retained Earnings: Retained Earnings decreased to -9,020 million in 2023 from -8,652 million in 2022 representing a change of -4.24%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 363 million in 2023 from 286 million in 2022 representing a change of 26.95%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	1532099000	1532099000	0.00
total liabilities	1064443000	1064443000	0.00
total equity	467656000	467656000	0.00
cash and cash equivalents	678856000	678856000	0.00
short term investments	178794000	178794000	0.00
long term investments	12673000	12673000	0.00
total current assets	1218274000	1218274000	0.00
total non current assets	313825000	313825000	0.00
total current liabilities	713197000	713197000	0.00
total non current liabilities	351246000	351246000	0.00
common stock	860000	860000	0.00
retained earnings	-9004028000	-9004028000	0.00
total debt	334668000	306422000	9.22

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 335 million in 2024Q2 from 306 million in 2024Q1 representing a change of 9.22%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	437987000	-184040000	337.98
operating cash flow	-588843000	-612469000	3.86
free cash flow	-653890000	-714290000	8.46
capital expenditure	-65047000	-101821000	36.12
depreciation and amortization	58190000	44540000	30.65
deferred income tax	0	0	NaN
stock based compensation	36993000	142062000	-73.96
accounts payables	0	-40465000	100.00
inventory	-95462000	30418000	-413.83
acquisitions net	0	0	NaN
investments in property plant and equipment	-15000	-101821000	99.99
net cash used for investing activites	619605000	365119000	69.70
debt repayment	91433000	37746000	142.23
common stock issued	341824000	2529000	13416.17
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	388355000	28467000	1264.23
cash at end of period	996671000	558684000	78.40
accounts receivables	-95305000	40465000	-335.52
cash at beginning of period	558684000	742724000	-24.78

Overall Score of Annual Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 438 million in 2023 from -184 million in 2022 representing a change of 337.98%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to -589 million in 2023 from -612 million in 2022 representing a change of 3.86%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -654 million in 2023 from -714 million in 2022 representing a change of 8.46%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 37 million in 2023 from 142 million in 2022 representing a change of -73.96%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 40 million in 2022 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -95 million in 2023 from 40 million in 2022 representing a change of -335.52%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -65 million in 2023 from -102 million in 2022 representing a change of 36.12%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	-93566000	-93566000	0.0
free cash flow	-93566000	-93566000	0.0
capital expenditure	0	0	NaN
depreciation and amortization	12003500	12003500	0.0
deferred income tax	0	0	NaN
stock based compensation	2325500	2325500	0.0
accounts receivables	-3328000	-3328000	0.0
accounts payables	0	0	NaN
inventory	-34619500	-34619500	0.0
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	-48864500	-48864500	0.0
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-17736500	-17736500	0.0
net change in cash	-158907500	-158907500	0.0
cash at end of period	-158907500	-158907500	0.0
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.37	0.41	-10.56
net income per share	-0.29	-0.82	64.66
operating cash flow per share	-0.47	-0.52	10.77
free cash flow per share	-0.52	-0.61	15.03
cash per share	0.81	0.89	-8.56
book value per share	0.36	0.38	-5.64
tangible book value per share	0.22	0.25	-9.06
shareholders equity per share	0.36	0.38	-5.64
interest debt per share	0.3	0.25	18.16
market cap	2575058501.92	4792739529.56	-46.27
enterprise value	1941835501.92	4520345529.56	-57.04
pe ratio	-7.01	-4.97	-41.13
price to sales ratio	5.55	9.96	-44.24
pocfratio	-4.37	-7.83	44.12
pfcf ratio	-3.94	-6.71	41.31
pb ratio	5.64	10.67	-47.15
ptb ratio	5.64	10.67	-47.15
ev to sales	4.19	9.39	-55.42
enterprise value over ebitda	-6.53	-5.32	-22.80
ev to operating cash flow	-3.3	-7.38	55.32
ev to free cash flow	-2.97	-6.33	53.07
earnings yield	-0.14	-0.2	29.14
free cash flow yield	-0.25	-0.15	-70.38
debt to equity	0.8	0.64	24.87
debt to assets	0.22	0.17	25.15
net debt to ebitda	2.13	0.32	564.54
current ratio	1.56	1.32	18.70
interest coverage	-45.23	-98.18	53.93
income quality	1.6	0.68	136.32
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.11	0.13	-19.97
research and ddevelopement to revenue	1.14	1.28	-10.82
intangibles to total assets	0.1	0.1	6.82
capex to operating cash flow	-0.11	-0.17	33.55
capex to revenue	0.14	0.21	-33.70
capex to depreciation	1.12	2.29	-51.10
stock based compensation to revenue	0.08	0.3	-72.98
graham number	1.54	2.66	-42.26
roic	-0.56	-1.21	53.42
return on tangible assets	-0.25	-0.65	62.19
graham net net	0.0	-0.07	106.24
working capital	479449000	300435000	59.58
tangible asset value	283785000	289627000	-2.02
net current asset value	124618000	57816000	115.54
invested capital	805862000	666700000	20.87
average receivables	124785500	97365500	28.16
average payables	268395500	352353500	-23.83
average inventory	65508000	41775500	56.81
days sales outstanding	135.69	58.49	132.00
days payables outstanding	563.64	522.21	7.93
days of inventory on hand	248.97	39.9	524.02
receivables turnover	2.69	6.24	-56.90
payables turnover	0.65	0.7	-7.35
inventory turnover	1.47	9.15	-83.97
roe	-0.8	-2.15	62.55
capex per share	0.05	0.09	-40.71

• Negative

  ROE: Return on Equity (ROE) increased to -0.80 on 2023-12-31 from -2.15 on 2022-12-31, representing a change of 62.55%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -7.01 on 2023-12-31 from -4.97 on 2022-12-31, representing a change of -41.13%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.56 on 2023-12-31 from 1.32 on 2022-12-31, representing a change of 18.70%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.80 on 2023-12-31 from 0.64 on 2022-12-31, representing a change of 24.87%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
2616.HK
calendar year	2024	2024	NaN
revenue per share	0.08	0.08	0.00
net income per share	0.01	0.01	0.00
operating cash flow per share	-0.06	-0.06	0.00
free cash flow per share	-0.06	-0.06	0.00
cash per share	0.55	0.55	0.00
book value per share	0.3	0.3	0.00
tangible book value per share	0.19	0.19	0.00
shareholders equity per share	0.3	0.3	0.00
interest debt per share	0.21	0.2	9.22
market cap	1664765917.2	1377461658	20.86
enterprise value	1320577917.2	1005027658	31.40
pe ratio	53.02	43.87	20.86
price to sales ratio	13.1	10.84	20.86
pocfratio	-17.79	-14.72	-20.86
pfcf ratio	-17.79	-14.72	-20.86
pb ratio	3.56	2.95	20.86
ptb ratio	3.56	2.95	20.86
ev to sales	10.39	7.91	31.40
enterprise value over ebitda	819.73	623.85	31.40
ev to operating cash flow	-14.11	-10.74	-31.40
ev to free cash flow	-14.11	-10.74	-31.40
earnings yield	0.0	0.01	-17.26
free cash flow yield	-0.06	-0.07	17.26
debt to equity	0.72	0.66	9.22
debt to assets	0.22	0.2	9.22
net debt to ebitda	-213.65	-231.18	7.58
current ratio	1.71	1.71	0.00
interest coverage	0	0	NaN
income quality	-11.92	-11.92	0.00
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.18	0.18	0.00
research and ddevelopement to revenue	0.26	0.26	0.00
intangibles to total assets	0.11	0.11	0.00
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0.02	0.02	0.00
graham number	0.18	0.18	0.00
roic	-0.0	-0.0	0.00
return on tangible assets	0.01	0.01	0.00
graham net net	0.01	0.01	0.00
working capital	505077000	505077000	0.00
tangible asset value	300450000	300450000	0.00
net current asset value	153831000	153831000	0.00
invested capital	803290000	803290000	0.00
average receivables	179094000	175766000	1.89
average payables	245042000	245709500	-0.27
average inventory	181530000	145179000	25.04
days sales outstanding	126.83	126.83	0.00
days payables outstanding	537.01	537.01	0.00
days of inventory on hand	397.82	397.82	0.00
receivables turnover	0.71	0.71	0.00
payables turnover	0.17	0.17	0.00
inventory turnover	0.23	0.23	0.00
roe	0.02	0.02	0.00
capex per share	0	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-06-30 Q2 from 0.02 on 2024-03-31 Q1, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 53.02 on 2024-06-30 Q2 from 43.87 on 2024-03-31 Q1, representing a change of 20.86%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.71 on 2024-06-30 Q2 from 1.71 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.72 on 2024-06-30 Q2 from 0.66 on 2024-03-31 Q1, representing a change of 9.22%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None